These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26110973)

  • 1. Likely effect of adding flexible sigmoidoscopy to the English NHS Bowel Cancer Screening Programme: impact on colorectal cancer cases and deaths.
    Geurts SM; Massat NJ; Duffy SW
    Br J Cancer; 2015 Jun; 113(1):142-9. PubMed ID: 26110973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of once-only flexible sigmoidoscopy screening on the outcomes of subsequent faecal occult blood test screening.
    Brown JP; Wooldrage K; Kralj-Hans I; Wright S; Cross AJ; Atkin WS
    J Med Screen; 2019 Mar; 26(1):11-18. PubMed ID: 30282520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
    Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
    Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.
    Hol L; van Leerdam ME; van Ballegooijen M; van Vuuren AJ; van Dekken H; Reijerink JC; van der Togt AC; Habbema JD; Kuipers EJ
    Gut; 2010 Jan; 59(1):62-8. PubMed ID: 19671542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Screening Modalities in Colorectal Cancer: A Network Meta-Analysis.
    Zhang J; Cheng Z; Ma Y; He C; Lu Y; Zhao Y; Chang X; Zhang Y; Bai Y; Cheng N
    Clin Colorectal Cancer; 2017 Dec; 16(4):252-263. PubMed ID: 28687458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and primary prevention of colorectal cancer: a review of sex-specific and site-specific differences.
    Massat NJ; Moss SM; Halloran SP; Duffy SW
    J Med Screen; 2013; 20(3):125-48. PubMed ID: 24197771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reappraisal of the options for colorectal cancer screening in England.
    Whyte S; Chilcott J; Halloran S
    Colorectal Dis; 2012 Sep; 14(9):e547-61. PubMed ID: 22390210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of stratifying by family history in colorectal cancer screening programs.
    Goede SL; Rabeneck L; Lansdorp-Vogelaar I; Zauber AG; Paszat LF; Hoch JS; Yong JH; van Hees F; Tinmouth J; van Ballegooijen M
    Int J Cancer; 2015 Sep; 137(5):1119-27. PubMed ID: 25663135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concerns, perceived need and competing priorities: a qualitative exploration of decision-making and non-participation in a population-based flexible sigmoidoscopy screening programme to prevent colorectal cancer.
    Hall N; Birt L; Rees CJ; Walter FM; Elliot S; Ritchie M; Weller D; Rubin G
    BMJ Open; 2016 Nov; 6(11):e012304. PubMed ID: 27836872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
    Tinmouth J; Lansdorp-Vogelaar I; Allison JE
    Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II.
    Rasmussen M; Fenger C; Kronborg O
    Scand J Gastroenterol; 2003 Jan; 38(1):114-8. PubMed ID: 12608473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Fitzpatrick-Lewis D; Ali MU; Warren R; Kenny M; Sherifali D; Raina P
    Clin Colorectal Cancer; 2016 Dec; 15(4):298-313. PubMed ID: 27133893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
    Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
    Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of faecal immunochemical test screening among nonparticipants in a flexible sigmoidoscopy screening programme.
    Hol L; Kuipers EJ; van Ballegooijen M; van Vuuren AJ; Reijerink JC; Habbema DJ; van Leerdam ME
    Int J Cancer; 2012 May; 130(9):2096-102. PubMed ID: 21702046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review.
    Gini A; Jansen EEL; Zielonke N; Meester RGS; Senore C; Anttila A; Segnan N; Mlakar DN; de Koning HJ; Lansdorp-Vogelaar I;
    Eur J Cancer; 2020 Mar; 127():224-235. PubMed ID: 31932176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
    Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
    Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planning for a possible national colorectal cancer screening programme.
    Garvican L
    J Med Screen; 1998; 5(4):187-94. PubMed ID: 9934649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of once-only flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: 21-year follow-up of the UK Flexible Sigmoidoscopy Screening randomised controlled trial.
    Wooldrage K; Robbins EC; Duffy SW; Cross AJ
    Lancet Gastroenterol Hepatol; 2024 Sep; 9(9):811-824. PubMed ID: 39038482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis.
    Elmunzer BJ; Singal AG; Sussman JB; Deshpande AR; Sussman DA; Conte ML; Dwamena BA; Rogers MA; Schoenfeld PS; Inadomi JM; Saini SD; Waljee AK
    Gastrointest Endosc; 2015 Mar; 81(3):700-709.e3. PubMed ID: 25708757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.